Dow Down 0.74% Nasdaq Down 0.93%

Portola Pharmaceuticals, Inc. (PTLA)

-NasdaqGS
23.80 Down 0.65(2.66%) 2:24PM EDT - Nasdaq Real Time Price
Prev Close:24.45
Open:24.26
Bid:23.98 x 200
Ask:24.02 x 100
1y Target Est:40.60
Beta:0.639649
Next Earnings Date: 5-May-16PTLA Earnings announcement
Day's Range:23.17 - 24.86
52wk Range:18.20 - 57.96
Volume:327,404
Avg Vol (3m):1,125,070
Market Cap:1.34B
P/E (ttm):N/A
EPS (ttm):-4.36
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for PTLA

Comparison

Symbol% ChgMkt Cap
PTLADown 2.66%1.34B
PFEUp 3.02%209.22B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):108.62
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-4.44
Quarterly EPS Est (Mar-16) :-1.06
Mean Recommendation*:1.8
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Portola Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes therapeutics for patients in the areas of thrombosis, other hematologic disorders, and inflammation. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback